Abstract
BackgroundIn most cancer patients with solid tumors, pre-existing dendritic cell (DC) activity is limited which impedes the ability of various immunotherapy agents to trigger an anti-tumor immune response. Toll-like receptor...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
